The Department of Dermatology’s staff and surgeons are at the forefront of the field, offering personal consultation and guidance to each patient. Continued research and state-of-the-art technology enables BMC’s physicians to develop more effective and less invasive techniques for treatments. We care for adult and pediatric patients providing the following treatments as appropriate:
For cosmetic dermatology services, visit the Boston University Cosmetic and Laser Center.
Treatment Cure Rates
Clinical studies demonstrate that Mohs micrographic surgery provides five-year cure rates of approximately 99% for primary basal cell carcinomas, and 96% for recurrent basal cell carcinoma. Cure rates for squamous cell carcinoma are approximately 97%.These cure rates are significantly higher than with other methods of tumor removal or destruction.
Mohs surgery is preferred over other treatments for:
- Tumors on the face
- Tumors on other body sites that may be difficult to repair if too much tissue is removed
- Recurrent (previously treated) tumors
- Large tumors or tumors without clearly defined edges
- Tumors that appear aggressive under the microscope